1. Home
  2. BIVI vs ABVE Comparison

BIVI vs ABVE Comparison

Compare BIVI & ABVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • ABVE
  • Stock Information
  • Founded
  • BIVI 2013
  • ABVE 2019
  • Country
  • BIVI United States
  • ABVE Canada
  • Employees
  • BIVI N/A
  • ABVE N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • ABVE Packaged Foods
  • Sector
  • BIVI Health Care
  • ABVE Consumer Staples
  • Exchange
  • BIVI Nasdaq
  • ABVE Nasdaq
  • Market Cap
  • BIVI 18.8M
  • ABVE 18.6M
  • IPO Year
  • BIVI N/A
  • ABVE N/A
  • Fundamental
  • Price
  • BIVI $0.86
  • ABVE $0.59
  • Analyst Decision
  • BIVI Strong Buy
  • ABVE
  • Analyst Count
  • BIVI 1
  • ABVE 0
  • Target Price
  • BIVI $30.00
  • ABVE N/A
  • AVG Volume (30 Days)
  • BIVI 230.4K
  • ABVE 306.1K
  • Earning Date
  • BIVI 05-13-2025
  • ABVE 02-15-2025
  • Dividend Yield
  • BIVI N/A
  • ABVE N/A
  • EPS Growth
  • BIVI N/A
  • ABVE N/A
  • EPS
  • BIVI N/A
  • ABVE N/A
  • Revenue
  • BIVI N/A
  • ABVE $275,376,450.00
  • Revenue This Year
  • BIVI N/A
  • ABVE N/A
  • Revenue Next Year
  • BIVI N/A
  • ABVE N/A
  • P/E Ratio
  • BIVI N/A
  • ABVE N/A
  • Revenue Growth
  • BIVI N/A
  • ABVE N/A
  • 52 Week Low
  • BIVI $0.80
  • ABVE $0.25
  • 52 Week High
  • BIVI $7.50
  • ABVE $4.07
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 36.17
  • ABVE N/A
  • Support Level
  • BIVI $0.80
  • ABVE N/A
  • Resistance Level
  • BIVI $1.00
  • ABVE N/A
  • Average True Range (ATR)
  • BIVI 0.10
  • ABVE 0.00
  • MACD
  • BIVI 0.01
  • ABVE 0.00
  • Stochastic Oscillator
  • BIVI 29.24
  • ABVE 0.00

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About ABVE Above Food Ingredients Inc. Common Stock

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

Share on Social Networks: